Evidence map›Paper›PMID 20200955›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2010

IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.

Jesse E Otero, Simon Dai, Muhammad A Alhawagri, Isra Darwech, Yousef Abu-Amer

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Differential Effects of a First-in-Class IKKCalcified tissue international · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Attenuation of NF-κB in Intestinal Epithelial Cells Is Sufficient to Mitigate the Bone Loss Comorbidity of Experimental Mouse Colitis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  11. miR-338-3p regulates osteoclastogenesis via targeting IKKβ gene.In vitro cellular & developmental biology. Animal · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Optimized Extract fromEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jesse E OteroDepartment of Orthopedics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Simon Dai
Muhammad A Alhawagri
Isra Darwech
Yousef Abu-Amer
Washington University in St. Louis · US

Funding

Regulatory Mechanisms of Implant-Induced OsteolysisR01AR049192 · NIAMS · WASHINGTON UNIVERSITY · PI ABU-AMER, YOUSEF · 2004 to 2019
$4.3M
Molecular Mechanisms Underlying Tak1 Function in OsteoclastsR01AR054326 · NIAMS · WASHINGTON UNIVERSITY · PI ABU-AMER, YOUSEF · 2008 to 2017
$3.3M
The Role of IKK2 in Osteoclastogenesis and Inflammatory Bone DestructionF31AR055392 · NIAMS · WASHINGTON UNIVERSITY · PI OTERO, JESSE ERNEST · 2007 to 2008
$50k
NIAMS NIH HHS AR049192NIAMS NIH HHS AR054326NIAMS NIH HHS AR055392-01NIAMS NIH HHS F31 AR055392NIAMS NIH HHS R01 AR049192NIAMS NIH HHS R01 AR054326
6 · The paper itself

Abstract

Monocytes differentiate into osteoclasts through stimulation of receptor activator of NF-kappaB (RANK). Many downstream effectors of RANK play a positive role in osteoclastogenesis, but their relative importance in osteoclast differentiation is unclear. We report the discovery that activation of a single pathway downstream of RANK is sufficient for osteoclast differentiation. In this regard, introduction of constitutively activated IKKbeta (IKKbeta(SSEE)) but not wild-type IKKbeta into monocytes stimulates differentiation of bona fide osteoclasts in the absence of RANK ligand (RANKL). This phenomenon is independent of upstream signals because IKKbeta(SSEE) induced the development of bone-resorbing osteoclasts from RANK and IKKalpha knockout monocytes and in conditions in which NEMO-IKKbeta association was inhibited. NF-kappaB p100 and p105, but not RelB, were critical mediators of this effect. Inflammatory autocrine signaling by tumor necrosis factor alpha (TNF-alpha) and interleukin 1 (IL-1) were dispensable for the spontaneous osteoclastogenesis driven by IKKbeta(SSEE). More important, adenoviral gene transfer of IKKbeta(SSEE) induced osteoclasts and osteolysis in calvariae and knees of mice. Our data establish the sufficiency of IKKbeta activation for osteolysis and suggest that IKKbeta hyperactivation may play a role in conditions of pathologic bone destruction refractory to RANK/RANKL proximal therapeutic interventions.

Indexed as

Cell DifferentiationAnimalsEnzyme ActivationI-kappa B KinaseIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutMonocytesNF-kappa BOsteoclastsOsteogenesisOsteolysisPhenotypeProtein BindingRANK LigandReceptor Activator of Nuclear Factor-kappa BChuk protein, mouseI-kappa B KinaseIkbkb protein, mouseIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa BRANK LigandReceptor Activator of Nuclear Factor-kappa B

Identifiers

PMID20200955
PMCPMC3153134
OpenAlexW2077760373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.